https://musculardystrophynews.com/news/myotonic-dystrophy-drug-srp-1003-trial-advances-higher-doses/
A Phase 1/2 clinical trial testing SRP-1003 for myotonic dystrophy type 1 is progressing with higher doses as planned.
myotonic dystrophydrugsrptrialadvances
https://www.nydmcenter.org/post/the-research-behind-myotonic-dystrophy
Myotonic Dystrophy is the most common cause of adult muscular dystrophy (DM) and has a surprisingly high prevalence in New York State of approximately one in...
the researchmyotonic dystrophybehind
https://www.myotonic.org/
The Myotonic Dystrophy Foundation (MDF) is the leading global advocate helping patients and families navigate the myotonic dystrophy (DM) disease process.
myotonic dystrophy foundation